Skip to content

efficacy of punarnavadi vati in the management of sthaulya with special reference to dyslipidemia in hypertension.

Prospective single arm open clinical trial to evaluate the efficacy of Punarnavadi Vati in the management of Sthaulya with special reference to Dyslipidemia in Hypertension.

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/09/074251
Enrollment
30
Registered
2024-09-24
Start date
Unknown
Completion date
Unknown
Last updated
2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E669- Obesity, unspecified

Interventions

None listed

Sponsors

Dr Shweta Santosh Shirsath
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 efficacy of punarnavadi vati in the management of sthaulya with special reference to dyslipidemia in hypertension. 2 Patients from age group of 18 to 60years irrespective of gender, religion, socio-economic status, marital status. 2 Patients of Sthaulya with hypertension as per signs and symptoms BMI between 25 to 34. Including overweight Obese class 1 as per signs and symptoms mentioned in Ayurvedic Samhitas. 3 Waist To hip Ratio more than 1. 4 Patient with known case of HTN Systolic BP should be less than 160 Diastolic BP should be less than 100

Exclusion criteria

Exclusion criteria: 1 Pregnant and lactating women. 2 Acute life threatening conditions like CVA, CA, Acute MI, DM I and Insulin Dependent. 3 Known Cases of Hypothyroidism and hyperthyroidism. 4 Patient with Systolic BP more than 160 diastolic BP more than 99

Design outcomes

Primary

MeasureTime frame
to evaluate the efficacy of Punarnavadi Vati In Sthaulya with special reference to Dyslipidemia in Hypertension.Timepoint: 15th and 30th day

Secondary

MeasureTime frame
1 To evaluate the efficacy of Punarnavadi Vati in Sthaulya with special reference to dyslipidemia in HTN. 2 To study the etiopathology of Sthaulya and Dyslipidemia 3 To study the of ingredients of Punarnvadi vati 4 To evaluate any adverse effect of Punarnvadi Vati if any. 5 To study the efficacy of Punarnavadi vati in blood pressure.Timepoint: 30 days

Countries

India

Contacts

Public ContactDr Shweta Santosh Shirsath

Seth Chandanmal Mutha Aryangla Vaidyak Mahavidyalaya, Satara

sameershubha85@gmail.com7507043414

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026